Orange Book product · Generic (ANDA)
ACETAZOLAMIDE SODIUM
ACETAZOLAMIDE SODIUM
At a glance
Dec 19, 2014
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2014
11 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
ACETAZOLAMIDE SODIUM
Strength
EQ 500MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 202693
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ACETAZOLAMIDE SODIUM
- —DIAMOXBrand (NDA)
NDA 009388 · TEVA WOMENS
- 2025ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 219775 · GLAND
- 2019ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 206533 · ZYDUS PHARMS
- 2017ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 205358 · PH HEALTH
- 2012ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 200880 · MYLAN ASI
- 2008ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 040784 · XGEN PHARMS
- 1995ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 040108 · HOSPIRA
- 1995ACETAZOLAMIDE SODIUMGeneric (ANDA)
ANDA 040089 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
